
Keywords: MI, myo-inositol; TMCS, trimethylchlorosilane; HMDS, hexamethyldisilazane; N,N-DMF, N,N-dimethylformamide; PI, phosphatidylinositol; PIP, phosphatidylinositol phosphateGas chromatography–mass spectrometry; Myo-inositol; Neural tube defects; Derivatives